Clearmind Medicine (CMND) - 2023 Q2 - Quarterly Report

CLEARMIND MEDICINE INC. (Unaudited) Condensed Interim Consolidated Statements of Financial Position (Expressed in United States Dollars) (Unaudited) Alan Rootenberg, Director, CFO Adi Zuloff-Shani, Director, CEO F-2 Condensed Interim Consolidated Statements of Operations and Comprehensive Loss (Expressed in United States Dollars) (Unaudited) On November 14, 2022, the Company completed a public offering for aggregate gross proceeds of US$7.5 million and up listing to the Nasdaq Capital Market ("Nasdaq"), see ...